Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Cancer Biomarker Chase Accelerates
Researchers Are Rapidly Gaining Ground in the Identification of These Early Warning Signals
- Expanding faster than the largest supernova, cancer biomarker development has become the priority of every single public and private entity performing cancer research nowadays. Evidence of this expansion comes in the form of multiple scientific conferences covering the topic. One of these conferences, IQPC’s “Oncology Biomarkers,” took place in ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.